1. Home
  2. NCA vs HRTX Comparison

NCA vs HRTX Comparison

Compare NCA & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCA
  • HRTX
  • Stock Information
  • Founded
  • NCA 1987
  • HRTX 1983
  • Country
  • NCA United States
  • HRTX United States
  • Employees
  • NCA N/A
  • HRTX N/A
  • Industry
  • NCA Investment Managers
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NCA Finance
  • HRTX Health Care
  • Exchange
  • NCA Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • NCA N/A
  • HRTX 350.4M
  • IPO Year
  • NCA N/A
  • HRTX 1987
  • Fundamental
  • Price
  • NCA $8.64
  • HRTX $2.17
  • Analyst Decision
  • NCA
  • HRTX Strong Buy
  • Analyst Count
  • NCA 0
  • HRTX 2
  • Target Price
  • NCA N/A
  • HRTX $5.50
  • AVG Volume (30 Days)
  • NCA 59.6K
  • HRTX 1.8M
  • Earning Date
  • NCA 01-01-0001
  • HRTX 05-06-2025
  • Dividend Yield
  • NCA 3.92%
  • HRTX N/A
  • EPS Growth
  • NCA N/A
  • HRTX N/A
  • EPS
  • NCA N/A
  • HRTX N/A
  • Revenue
  • NCA N/A
  • HRTX $148,518,000.00
  • Revenue This Year
  • NCA N/A
  • HRTX $11.18
  • Revenue Next Year
  • NCA N/A
  • HRTX $13.15
  • P/E Ratio
  • NCA N/A
  • HRTX N/A
  • Revenue Growth
  • NCA N/A
  • HRTX 12.43
  • 52 Week Low
  • NCA $7.77
  • HRTX $1.04
  • 52 Week High
  • NCA $9.12
  • HRTX $3.93
  • Technical
  • Relative Strength Index (RSI)
  • NCA 62.72
  • HRTX 49.30
  • Support Level
  • NCA $8.42
  • HRTX $2.00
  • Resistance Level
  • NCA $8.58
  • HRTX $2.61
  • Average True Range (ATR)
  • NCA 0.09
  • HRTX 0.18
  • MACD
  • NCA 0.03
  • HRTX 0.01
  • Stochastic Oscillator
  • NCA 100.00
  • HRTX 45.00

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: